跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IBUPROFENO KABI 400 MG SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IBUPROFENO KABI 400 MG SOLUCION PARA PERFUSION
Approved
STANDARD
IBUPROFENO KABI 400 MG SOLUCION PARA PERFUSION
Fresenius Kabi España, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 30, 2021
Approval ID
6b9b3e4db974b871
Company
Fresenius Kabi España, S.A.U.
Type
Standard
Approval Details
Approval Id
6b9b3e4db974b871
Drug Cima Aemps Name
IBUPROFENO KABI 400 MG SOLUCION PARA PERFUSION
Register Number
85580
Holder Company Name
Fresenius Kabi España, S.A.U.
Marketing Company Name
Fresenius Kabi España, S.A.U.
Authorization Date
2021-07-30
Dosage Form
SOLUCIÓN PARA PERFUSIÓN
Dose
4 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Fresenius Kabi España, S.A.U.
Active Ingredients
IBUPROFENO
4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 30, 2021
Approval ID
6b9b3e4db974b871
Type
Standard
Back to CIMA-AEMPS Approvals
